What's in Chiesi Farmaceutici S.p.A.'s pipeline?

Chiesi Farmaceutici S.p.A. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Chiesi Farmaceutici S.p.A.'s portfolio?

Top competitors by shared drug class: Chiesi Farmaceutici S.P.A, Sanofi.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/chiesi-farmaceutici-spa.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Chiesi Farmaceutici S.p.A. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chiesi Farmaceutici S.p.A. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ELFABRIO	PEGUNIGALSIDASE ALFA-IWXJ	marketed	Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]		Rare Disease

Therapeutic area mix

Rare Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Chiesi Farmaceutici S.P.A · 1 shared drug class
Sanofi · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Chiesi Farmaceutici S.p.A.:

Cite this brief

Drug Landscape (2026). Chiesi Farmaceutici S.p.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/chiesi-farmaceutici-spa. Accessed 2026-06-10.